Latest filing published 29 May 2026 for GENOWAY, €9,706.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Jean Louis Menard on record concern Genoway, in the capacity of board member. Between 17 December 2025 and 28 May 2026, the trades on record add up to 2 filings.
In open-market terms, that means 1 purchase worth €90k on one side and 1 sale worth €9,706 on the other. Netting one side against the other leaves €81k of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at no purchases and 1 sale.
Most recently, on 29 May 2026, the filings show an open-market sale worth €9,706 in Genoway. The last insider purchase was made public on 23 December 2025, 305 days ago. This summary is built from AMF disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations